Seoul, South Korea

Soo Been Park

This inventor holds 1 USPTO granted patent. Top assignee: Yonsei University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soo Been Park. Retrieved from https://idiyas.com/inventor/soo-been-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Soo Been Park

Introduction

Soo Been Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical research, particularly in the area of pancreatic cancer. His work focuses on the development of novel biomarkers that can aid in the early detection and diagnosis of this challenging disease.

Latest Patents

Soo Been Park holds a patent titled "Pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof." This invention relates to a novel molecular marker for pancreatic cancer stem cells and pancreatic cancer. The patent describes a marker detection method and a screening method that can identify pancreatic cancer, especially in its early stages. The marker discovered from pancreatic cancer cell lines enables accurate diagnosis and prognosis analysis of pancreatic cancer. He has 1 patent to his name.

Career Highlights

Soo Been Park is affiliated with Yonsei University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential impact on cancer diagnostics and treatment strategies.

Collaborations

He has collaborated with notable colleagues, including Si Young Song and Sun Ae Kim, to advance research in the field of cancer biomarkers.

Conclusion

Soo Been Park's innovative work in developing pancreatic cancer biomarkers represents a significant advancement in medical research. His contributions have the potential to improve early detection and treatment outcomes for patients suffering from pancreatic cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…